blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1515959

EP1515959 - PHARMACEUTICAL SALTS OF REBOXETINE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.06.2010
Database last updated on 07.04.2026
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
Pfizer Italia S.r.l.
Strada Statale 156 Km. 50
04010 Latina / IT
[2006/31]
Former [2005/12]For all designated states
Pharmacia Italia S.p.A.
Via Robert Koch, 1.2
20152 Milano / IT
Inventor(s)01 / ZAMPIERI, Massimo
Via Luigi Madorati, 1
I-20052 Monza / IT
02 / AIROLDI, Annalisa
Via Roma, 10
I-20020 Nosate / IT
03 / MARTINI, Alessandro
Via Desiderio da Settignano, 14
I-20149 Milano / IT
 [2005/12]
Representative(s)Summers, Victoria Clare, et al
ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR
[N/P]
Former [2009/07]Summers, Victoria Clare, et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Former [2005/12]Duncan, Garreth Andrew, et al
Pfizer Limited, European Pharma Patent Department, Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date03725195.604.06.2003
[2005/12]
WO2003EP05261
Priority number, dateEP2002007736617.06.2002         Original published format: EP 02077366
[2005/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03106441
Date:24.12.2003
Language:EN
[2003/52]
Type: A1 Application with search report 
No.:EP1515959
Date:23.03.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 24.12.2003 takes the place of the publication of the European patent application.
[2005/12]
Type: B1 Patent specification 
No.:EP1515959
Date:12.08.2009
Language:EN
[2009/33]
Search report(s)International search report - published on:EP24.12.2003
ClassificationIPC:C07D265/30, A61K31/5375, A61P25/24
[2005/12]
CPC:
A61K31/5375 (EP,US); C07D265/30 (EP,KR,US); A61P1/14 (EP);
A61P13/10 (EP); A61P15/00 (EP); A61P17/02 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P25/02 (EP);
A61P25/14 (EP); A61P25/18 (EP); A61P25/20 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P25/32 (EP); A61P25/34 (EP); A61P25/36 (EP);
A61P29/00 (EP); A61P3/02 (EP); A61P3/04 (EP);
A61P3/10 (EP); A61P39/02 (EP); A61P43/00 (EP);
A61P5/06 (EP); A61P5/24 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/12]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:PHARMAZEUTISCHE SALZE VON REBOXETIN[2005/12]
English:PHARMACEUTICAL SALTS OF REBOXETINE[2005/12]
French:SELS PHARMACEUTIQUES DE REBOXETINE[2005/12]
Entry into regional phase17.01.2005National basic fee paid 
17.01.2005Designation fee(s) paid 
17.01.2005Examination fee paid 
Examination procedure26.11.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
24.02.2004Amendment by applicant (claims and/or description)
17.01.2005Examination requested  [2005/12]
27.11.2008Communication of intention to grant the patent
10.03.2009Fee for grant paid
10.03.2009Fee for publishing/printing paid
Opposition(s)17.05.2010No opposition filed within time limit [2010/29]
Fees paidRenewal fee
30.06.2005Renewal fee patent year 03
30.06.2006Renewal fee patent year 04
02.07.2007Renewal fee patent year 05
30.06.2008Renewal fee patent year 06
30.06.2009Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.08.2009
BE12.08.2009
CY12.08.2009
CZ12.08.2009
EE12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
TR12.08.2009
BG12.11.2009
GR13.11.2009
PT12.12.2009
HU13.02.2010
[2012/47]
Former [2012/42]AT12.08.2009
BE12.08.2009
CY12.08.2009
CZ12.08.2009
EE12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
GR13.11.2009
PT12.12.2009
HU13.02.2010
Former [2012/37]AT12.08.2009
BE12.08.2009
CY12.08.2009
CZ12.08.2009
EE12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
GR13.11.2009
PT12.12.2009
Former [2010/48]AT12.08.2009
BE12.08.2009
CZ12.08.2009
EE12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
GR13.11.2009
PT12.12.2009
Former [2010/28]AT12.08.2009
BE12.08.2009
CZ12.08.2009
EE12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
PT12.12.2009
Former [2010/23]AT12.08.2009
CZ12.08.2009
EE12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
PT12.12.2009
Former [2010/22]AT12.08.2009
CZ12.08.2009
EE12.08.2009
RO12.08.2009
SI12.08.2009
BG12.11.2009
PT12.12.2009
Former [2010/20]AT12.08.2009
EE12.08.2009
SI12.08.2009
BG12.11.2009
PT12.12.2009
Former [2010/18]AT12.08.2009
SI12.08.2009
BG12.11.2009
PT12.12.2009
Former [2010/16]AT12.08.2009
SI12.08.2009
PT12.12.2009
Former [2010/11]AT12.08.2009
SI12.08.2009
Former [2010/08]AT12.08.2009
Cited inInternational search[X]   MELLONI P ET AL: "CONFIGURATIONAL STUDIES ON 2-ALPHA-(2-ETHOXYPHENOXY)BENZYLMORPHOLINE FCE 20124", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 41, no. 7, 1985, pages 1393 - 1399, XP000989980, ISSN: 0040-4020 [X] 11 * page 1395, line 7 - line 11 *

DOI:   http://dx.doi.org/10.1016/S0040-4020(01)96541-X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.